"title","geo_accession","status","submission_date","last_update_date","type","channel_count","source_name_ch1","organism_ch1","characteristics_ch1","characteristics_ch1.1","treatment_protocol_ch1","growth_protocol_ch1","molecule_ch1","extract_protocol_ch1","label_ch1","label_protocol_ch1","taxid_ch1","source_name_ch2","organism_ch2","characteristics_ch2","characteristics_ch2.1","treatment_protocol_ch2","growth_protocol_ch2","molecule_ch2","extract_protocol_ch2","label_ch2","label_protocol_ch2","taxid_ch2","hyb_protocol","scan_protocol","data_processing","platform_id","contact_name","contact_email","contact_institute","contact_address","contact_city","contact_zip/postal_code","contact_country","supplementary_file","data_row_count","agent:ch1","agent:ch2","tissue:ch1","tissue:ch2"
"Mock-treated BMSC sample M48","GSM2399028","Public on Sep 05 2018","Nov 22 2016","Sep 05 2018","RNA","2","Reference sample: pool of 5 samples of bone marrow-derived mesenchymal stromal cells","Homo sapiens","tissue: Bone marrow-derived mesenchymal stromal cells","agent: none","Five million detached BM-hMSCs were concentrated at 30 x 106 cells/ml in HBSS, without Ca2+ or Mg2+ (Gibco), containing 10 mM HEPES, 0.1 % human serum albumin (Sigma-Aldrich). Each sample was divided into two reaction tubes, buffer alone, and the other with 60 mU/ml of FTVI or FTVII (obtained from R&D Systems), as specified in each case, containing  1 mM GDP-fucose (Sigma-Aldrich) as enzyme substrate. Reactions were performed at 37 oC for 1 h with gentle shaking, followed by centrifugation and washing with DPBS.","BM mononuclear cells (BMMNC) were isolated by density gradient centrifugation over Histopaque-1077 (Sigma-Aldrich, St Louis, MO).  Human Platelet Lysate was obtained from platelet concentrates, which were frozen at –80 ºC for at least 3 days, thawed at 37 oC, transferred to sterile tubes and centrifuged at 900 g for 30 min; the supernatants were pooled, aliquoted and stored at –20ºC. BMMNC were seeded in culture flasks at 160,000 cells/cm2 using low glucose DMEM (GIBCO Invitrogen Corporation, Gran Island, NY, USA) supplemented with 5 % HPL, plus 50 U/ml penicillin and 50 U/ml streptomycin, and heparin (2U/ml) incubated at 37oC in a humid atmosphere with 5 % CO2. First change of medium was performed at 24 h and from this point twice per week. First passage was made when cells achieved 60-80% confluence. Culture media was removed and culture flasks were washed with DPBS, then incubated with TrypLE Select reagent (GIBCO Invitrogen Corporation, Gran Island, NY, USA). Cells were pooled, centrifuged at 700 g for 5 min and seeded at a density of 1,000 cells/cm2. After the third passage, BM-hMSCs were harvested.","total RNA","RNAs were isolated using the miRNeasy mini kit (Qiagen) protocol following the manufacturer's instructions","Cy3","Agilent Two Color Quick Amp Labeling and RNA Spike-In kits protocols following the manufacturer's instructions","9606","Test sample: mock-treated bone marrow-derived mesenchymal stromal cells sample M48","Homo sapiens","tissue: Bone marrow-derived mesenchymal stromal cells sample M48","agent: mock","Five million detached BM-hMSCs were concentrated at 30 x 106 cells/ml in HBSS, without Ca2+ or Mg2+ (Gibco), containing 10 mM HEPES, 0.1 % human serum albumin (Sigma-Aldrich). Each sample was divided into two reaction tubes, buffer alone, and the other with 60 mU/ml of FTVI or FTVII (obtained from R&D Systems), as specified in each case, containing  1 mM GDP-fucose (Sigma-Aldrich) as enzyme substrate. Reactions were performed at 37 oC for 1 h with gentle shaking, followed by centrifugation and washing with DPBS.","BM mononuclear cells (BMMNC) were isolated by density gradient centrifugation over Histopaque-1077 (Sigma-Aldrich, St Louis, MO).  Human Platelet Lysate was obtained from platelet concentrates, which were frozen at –80 ºC for at least 3 days, thawed at 37 oC, transferred to sterile tubes and centrifuged at 900 g for 30 min; the supernatants were pooled, aliquoted and stored at –20ºC. BMMNC were seeded in culture flasks at 160,000 cells/cm2 using low glucose DMEM (GIBCO Invitrogen Corporation, Gran Island, NY, USA) supplemented with 5 % HPL, plus 50 U/ml penicillin and 50 U/ml streptomycin, and heparin (2U/ml) incubated at 37oC in a humid atmosphere with 5 % CO2. First change of medium was performed at 24 h and from this point twice per week. First passage was made when cells achieved 60-80% confluence. Culture media was removed and culture flasks were washed with DPBS, then incubated with TrypLE Select reagent (GIBCO Invitrogen Corporation, Gran Island, NY, USA). Cells were pooled, centrifuged at 700 g for 5 min and seeded at a density of 1,000 cells/cm2. After the third passage, BM-hMSCs were harvested.","total RNA","RNAs were isolated using the miRNeasy mini kit (Qiagen) protocol following the manufacturer's instructions","Cy5","Agilent Two Color Quick Amp Labeling and RNA Spike-In kits protocols following the manufacturer's instructions","9606","Agilent Gene Expression Hybridization kit protocol following the manufacturer's instructions","Agilent G2565CA scanner, Agilent Scan Control software, scanning at 3µm","Agilent Feature Extraction software version 11.0.1.1","GPL16699","Antonio,,Parrado","antonio.parrado@carm.es","Hospital Clinico Universitario Virgen de la Arrixaca","Ctra. Madrid-Cartagena, s/n","Murcia","30120","Spain","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2399nnn/GSM2399028/suppl/GSM2399028_01C_M48.txt.gz","62976","none","mock","Bone marrow-derived mesenchymal stromal cells","Bone marrow-derived mesenchymal stromal cells sample M48"
"FTVI-treated BMSC sample M48","GSM2399029","Public on Sep 05 2018","Nov 22 2016","Sep 05 2018","RNA","2","Reference sample: pool of 5 samples of bone marrow-derived mesenchymal stromal cells","Homo sapiens","tissue: Bone marrow-derived mesenchymal stromal cells","agent: none","Five million detached BM-hMSCs were concentrated at 30 x 106 cells/ml in HBSS, without Ca2+ or Mg2+ (Gibco), containing 10 mM HEPES, 0.1 % human serum albumin (Sigma-Aldrich). Each sample was divided into two reaction tubes, buffer alone, and the other with 60 mU/ml of FTVI or FTVII (obtained from R&D Systems), as specified in each case, containing  1 mM GDP-fucose (Sigma-Aldrich) as enzyme substrate. Reactions were performed at 37 oC for 1 h with gentle shaking, followed by centrifugation and washing with DPBS.","BM mononuclear cells (BMMNC) were isolated by density gradient centrifugation over Histopaque-1077 (Sigma-Aldrich, St Louis, MO).  Human Platelet Lysate was obtained from platelet concentrates, which were frozen at –80 ºC for at least 3 days, thawed at 37 oC, transferred to sterile tubes and centrifuged at 900 g for 30 min; the supernatants were pooled, aliquoted and stored at –20ºC. BMMNC were seeded in culture flasks at 160,000 cells/cm2 using low glucose DMEM (GIBCO Invitrogen Corporation, Gran Island, NY, USA) supplemented with 5 % HPL, plus 50 U/ml penicillin and 50 U/ml streptomycin, and heparin (2U/ml) incubated at 37oC in a humid atmosphere with 5 % CO2. First change of medium was performed at 24 h and from this point twice per week. First passage was made when cells achieved 60-80% confluence. Culture media was removed and culture flasks were washed with DPBS, then incubated with TrypLE Select reagent (GIBCO Invitrogen Corporation, Gran Island, NY, USA). Cells were pooled, centrifuged at 700 g for 5 min and seeded at a density of 1,000 cells/cm2. After the third passage, BM-hMSCs were harvested.","total RNA","RNAs were isolated using the miRNeasy mini kit (Qiagen) protocol following the manufacturer's instructions","Cy3","Agilent Two Color Quick Amp Labeling and RNA Spike-In kits protocols following the manufacturer's instructions","9606","Test sample: FTVI-treated bone marrow-derived mesenchymal stromal cells sample M48","Homo sapiens","tissue: Bone marrow-derived mesenchymal stromal cells sample M48","agent: FTVI","Five million detached BM-hMSCs were concentrated at 30 x 106 cells/ml in HBSS, without Ca2+ or Mg2+ (Gibco), containing 10 mM HEPES, 0.1 % human serum albumin (Sigma-Aldrich). Each sample was divided into two reaction tubes, buffer alone, and the other with 60 mU/ml of FTVI or FTVII (obtained from R&D Systems), as specified in each case, containing  1 mM GDP-fucose (Sigma-Aldrich) as enzyme substrate. Reactions were performed at 37 oC for 1 h with gentle shaking, followed by centrifugation and washing with DPBS.","BM mononuclear cells (BMMNC) were isolated by density gradient centrifugation over Histopaque-1077 (Sigma-Aldrich, St Louis, MO).  Human Platelet Lysate was obtained from platelet concentrates, which were frozen at –80 ºC for at least 3 days, thawed at 37 oC, transferred to sterile tubes and centrifuged at 900 g for 30 min; the supernatants were pooled, aliquoted and stored at –20ºC. BMMNC were seeded in culture flasks at 160,000 cells/cm2 using low glucose DMEM (GIBCO Invitrogen Corporation, Gran Island, NY, USA) supplemented with 5 % HPL, plus 50 U/ml penicillin and 50 U/ml streptomycin, and heparin (2U/ml) incubated at 37oC in a humid atmosphere with 5 % CO2. First change of medium was performed at 24 h and from this point twice per week. First passage was made when cells achieved 60-80% confluence. Culture media was removed and culture flasks were washed with DPBS, then incubated with TrypLE Select reagent (GIBCO Invitrogen Corporation, Gran Island, NY, USA). Cells were pooled, centrifuged at 700 g for 5 min and seeded at a density of 1,000 cells/cm2. After the third passage, BM-hMSCs were harvested.","total RNA","RNAs were isolated using the miRNeasy mini kit (Qiagen) protocol following the manufacturer's instructions","Cy5","Agilent Two Color Quick Amp Labeling and RNA Spike-In kits protocols following the manufacturer's instructions","9606","Agilent Gene Expression Hybridization kit protocol following the manufacturer's instructions","Agilent G2565CA scanner, Agilent Scan Control software, scanning at 3µm","Agilent Feature Extraction software version 11.0.1.1","GPL16699","Antonio,,Parrado","antonio.parrado@carm.es","Hospital Clinico Universitario Virgen de la Arrixaca","Ctra. Madrid-Cartagena, s/n","Murcia","30120","Spain","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2399nnn/GSM2399029/suppl/GSM2399029_01F_M48.txt.gz","62976","none","FTVI","Bone marrow-derived mesenchymal stromal cells","Bone marrow-derived mesenchymal stromal cells sample M48"
"Mock-treated BMSC sample RP-002","GSM2399030","Public on Sep 05 2018","Nov 22 2016","Sep 05 2018","RNA","2","Reference sample: pool of 5 samples of bone marrow-derived mesenchymal stromal cells","Homo sapiens","tissue: Bone marrow-derived mesenchymal stromal cells","agent: none","Five million detached BM-hMSCs were concentrated at 30 x 106 cells/ml in HBSS, without Ca2+ or Mg2+ (Gibco), containing 10 mM HEPES, 0.1 % human serum albumin (Sigma-Aldrich). Each sample was divided into two reaction tubes, buffer alone, and the other with 60 mU/ml of FTVI or FTVII (obtained from R&D Systems), as specified in each case, containing  1 mM GDP-fucose (Sigma-Aldrich) as enzyme substrate. Reactions were performed at 37 oC for 1 h with gentle shaking, followed by centrifugation and washing with DPBS.","BM mononuclear cells (BMMNC) were isolated by density gradient centrifugation over Histopaque-1077 (Sigma-Aldrich, St Louis, MO).  Human Platelet Lysate was obtained from platelet concentrates, which were frozen at –80 ºC for at least 3 days, thawed at 37 oC, transferred to sterile tubes and centrifuged at 900 g for 30 min; the supernatants were pooled, aliquoted and stored at –20ºC. BMMNC were seeded in culture flasks at 160,000 cells/cm2 using low glucose DMEM (GIBCO Invitrogen Corporation, Gran Island, NY, USA) supplemented with 5 % HPL, plus 50 U/ml penicillin and 50 U/ml streptomycin, and heparin (2U/ml) incubated at 37oC in a humid atmosphere with 5 % CO2. First change of medium was performed at 24 h and from this point twice per week. First passage was made when cells achieved 60-80% confluence. Culture media was removed and culture flasks were washed with DPBS, then incubated with TrypLE Select reagent (GIBCO Invitrogen Corporation, Gran Island, NY, USA). Cells were pooled, centrifuged at 700 g for 5 min and seeded at a density of 1,000 cells/cm2. After the third passage, BM-hMSCs were harvested.","total RNA","RNAs were isolated using the miRNeasy mini kit (Qiagen) protocol following the manufacturer's instructions","Cy3","Agilent Two Color Quick Amp Labeling and RNA Spike-In kits protocols following the manufacturer's instructions","9606","Test sample: mock-treated bone marrow-derived mesenchymal stromal cells sample RP-002","Homo sapiens","tissue: Bone marrow-derived mesenchymal stromal cells sample RP-002","agent: mock","Five million detached BM-hMSCs were concentrated at 30 x 106 cells/ml in HBSS, without Ca2+ or Mg2+ (Gibco), containing 10 mM HEPES, 0.1 % human serum albumin (Sigma-Aldrich). Each sample was divided into two reaction tubes, buffer alone, and the other with 60 mU/ml of FTVI or FTVII (obtained from R&D Systems), as specified in each case, containing  1 mM GDP-fucose (Sigma-Aldrich) as enzyme substrate. Reactions were performed at 37 oC for 1 h with gentle shaking, followed by centrifugation and washing with DPBS.","BM mononuclear cells (BMMNC) were isolated by density gradient centrifugation over Histopaque-1077 (Sigma-Aldrich, St Louis, MO).  Human Platelet Lysate was obtained from platelet concentrates, which were frozen at –80 ºC for at least 3 days, thawed at 37 oC, transferred to sterile tubes and centrifuged at 900 g for 30 min; the supernatants were pooled, aliquoted and stored at –20ºC. BMMNC were seeded in culture flasks at 160,000 cells/cm2 using low glucose DMEM (GIBCO Invitrogen Corporation, Gran Island, NY, USA) supplemented with 5 % HPL, plus 50 U/ml penicillin and 50 U/ml streptomycin, and heparin (2U/ml) incubated at 37oC in a humid atmosphere with 5 % CO2. First change of medium was performed at 24 h and from this point twice per week. First passage was made when cells achieved 60-80% confluence. Culture media was removed and culture flasks were washed with DPBS, then incubated with TrypLE Select reagent (GIBCO Invitrogen Corporation, Gran Island, NY, USA). Cells were pooled, centrifuged at 700 g for 5 min and seeded at a density of 1,000 cells/cm2. After the third passage, BM-hMSCs were harvested.","total RNA","RNAs were isolated using the miRNeasy mini kit (Qiagen) protocol following the manufacturer's instructions","Cy5","Agilent Two Color Quick Amp Labeling and RNA Spike-In kits protocols following the manufacturer's instructions","9606","Agilent Gene Expression Hybridization kit protocol following the manufacturer's instructions","Agilent G2565CA scanner, Agilent Scan Control software, scanning at 3µm","Agilent Feature Extraction software version 11.0.1.1","GPL16699","Antonio,,Parrado","antonio.parrado@carm.es","Hospital Clinico Universitario Virgen de la Arrixaca","Ctra. Madrid-Cartagena, s/n","Murcia","30120","Spain","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2399nnn/GSM2399030/suppl/GSM2399030_05C_RP-002.txt.gz","62976","none","mock","Bone marrow-derived mesenchymal stromal cells","Bone marrow-derived mesenchymal stromal cells sample RP-002"
"FTVI-treated BMSC sample RP-002","GSM2399031","Public on Sep 05 2018","Nov 22 2016","Sep 05 2018","RNA","2","Reference sample: pool of 5 samples of bone marrow-derived mesenchymal stromal cells","Homo sapiens","tissue: Bone marrow-derived mesenchymal stromal cells","agent: none","Five million detached BM-hMSCs were concentrated at 30 x 106 cells/ml in HBSS, without Ca2+ or Mg2+ (Gibco), containing 10 mM HEPES, 0.1 % human serum albumin (Sigma-Aldrich). Each sample was divided into two reaction tubes, buffer alone, and the other with 60 mU/ml of FTVI or FTVII (obtained from R&D Systems), as specified in each case, containing  1 mM GDP-fucose (Sigma-Aldrich) as enzyme substrate. Reactions were performed at 37 oC for 1 h with gentle shaking, followed by centrifugation and washing with DPBS.","BM mononuclear cells (BMMNC) were isolated by density gradient centrifugation over Histopaque-1077 (Sigma-Aldrich, St Louis, MO).  Human Platelet Lysate was obtained from platelet concentrates, which were frozen at –80 ºC for at least 3 days, thawed at 37 oC, transferred to sterile tubes and centrifuged at 900 g for 30 min; the supernatants were pooled, aliquoted and stored at –20ºC. BMMNC were seeded in culture flasks at 160,000 cells/cm2 using low glucose DMEM (GIBCO Invitrogen Corporation, Gran Island, NY, USA) supplemented with 5 % HPL, plus 50 U/ml penicillin and 50 U/ml streptomycin, and heparin (2U/ml) incubated at 37oC in a humid atmosphere with 5 % CO2. First change of medium was performed at 24 h and from this point twice per week. First passage was made when cells achieved 60-80% confluence. Culture media was removed and culture flasks were washed with DPBS, then incubated with TrypLE Select reagent (GIBCO Invitrogen Corporation, Gran Island, NY, USA). Cells were pooled, centrifuged at 700 g for 5 min and seeded at a density of 1,000 cells/cm2. After the third passage, BM-hMSCs were harvested.","total RNA","RNAs were isolated using the miRNeasy mini kit (Qiagen) protocol following the manufacturer's instructions","Cy3","Agilent Two Color Quick Amp Labeling and RNA Spike-In kits protocols following the manufacturer's instructions","9606","Test sample: FTVI-treated bone marrow-derived mesenchymal stromal cells sample RP-002","Homo sapiens","tissue: Bone marrow-derived mesenchymal stromal cells sample RP-002","agent: FTVI","Five million detached BM-hMSCs were concentrated at 30 x 106 cells/ml in HBSS, without Ca2+ or Mg2+ (Gibco), containing 10 mM HEPES, 0.1 % human serum albumin (Sigma-Aldrich). Each sample was divided into two reaction tubes, buffer alone, and the other with 60 mU/ml of FTVI or FTVII (obtained from R&D Systems), as specified in each case, containing  1 mM GDP-fucose (Sigma-Aldrich) as enzyme substrate. Reactions were performed at 37 oC for 1 h with gentle shaking, followed by centrifugation and washing with DPBS.","BM mononuclear cells (BMMNC) were isolated by density gradient centrifugation over Histopaque-1077 (Sigma-Aldrich, St Louis, MO).  Human Platelet Lysate was obtained from platelet concentrates, which were frozen at –80 ºC for at least 3 days, thawed at 37 oC, transferred to sterile tubes and centrifuged at 900 g for 30 min; the supernatants were pooled, aliquoted and stored at –20ºC. BMMNC were seeded in culture flasks at 160,000 cells/cm2 using low glucose DMEM (GIBCO Invitrogen Corporation, Gran Island, NY, USA) supplemented with 5 % HPL, plus 50 U/ml penicillin and 50 U/ml streptomycin, and heparin (2U/ml) incubated at 37oC in a humid atmosphere with 5 % CO2. First change of medium was performed at 24 h and from this point twice per week. First passage was made when cells achieved 60-80% confluence. Culture media was removed and culture flasks were washed with DPBS, then incubated with TrypLE Select reagent (GIBCO Invitrogen Corporation, Gran Island, NY, USA). Cells were pooled, centrifuged at 700 g for 5 min and seeded at a density of 1,000 cells/cm2. After the third passage, BM-hMSCs were harvested.","total RNA","RNAs were isolated using the miRNeasy mini kit (Qiagen) protocol following the manufacturer's instructions","Cy5","Agilent Two Color Quick Amp Labeling and RNA Spike-In kits protocols following the manufacturer's instructions","9606","Agilent Gene Expression Hybridization kit protocol following the manufacturer's instructions","Agilent G2565CA scanner, Agilent Scan Control software, scanning at 3µm","Agilent Feature Extraction software version 11.0.1.1","GPL16699","Antonio,,Parrado","antonio.parrado@carm.es","Hospital Clinico Universitario Virgen de la Arrixaca","Ctra. Madrid-Cartagena, s/n","Murcia","30120","Spain","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2399nnn/GSM2399031/suppl/GSM2399031_05F_RP-002.txt.gz","62976","none","FTVI","Bone marrow-derived mesenchymal stromal cells","Bone marrow-derived mesenchymal stromal cells sample RP-002"
"Mock-treated BMSC sample M41-P3","GSM2399032","Public on Sep 05 2018","Nov 22 2016","Sep 05 2018","RNA","2","Reference sample: pool of 5 samples of bone marrow-derived mesenchymal stromal cells","Homo sapiens","tissue: Bone marrow-derived mesenchymal stromal cells","agent: none","Five million detached BM-hMSCs were concentrated at 30 x 106 cells/ml in HBSS, without Ca2+ or Mg2+ (Gibco), containing 10 mM HEPES, 0.1 % human serum albumin (Sigma-Aldrich). Each sample was divided into two reaction tubes, buffer alone, and the other with 60 mU/ml of FTVI or FTVII (obtained from R&D Systems), as specified in each case, containing  1 mM GDP-fucose (Sigma-Aldrich) as enzyme substrate. Reactions were performed at 37 oC for 1 h with gentle shaking, followed by centrifugation and washing with DPBS.","BM mononuclear cells (BMMNC) were isolated by density gradient centrifugation over Histopaque-1077 (Sigma-Aldrich, St Louis, MO).  Human Platelet Lysate was obtained from platelet concentrates, which were frozen at –80 ºC for at least 3 days, thawed at 37 oC, transferred to sterile tubes and centrifuged at 900 g for 30 min; the supernatants were pooled, aliquoted and stored at –20ºC. BMMNC were seeded in culture flasks at 160,000 cells/cm2 using low glucose DMEM (GIBCO Invitrogen Corporation, Gran Island, NY, USA) supplemented with 5 % HPL, plus 50 U/ml penicillin and 50 U/ml streptomycin, and heparin (2U/ml) incubated at 37oC in a humid atmosphere with 5 % CO2. First change of medium was performed at 24 h and from this point twice per week. First passage was made when cells achieved 60-80% confluence. Culture media was removed and culture flasks were washed with DPBS, then incubated with TrypLE Select reagent (GIBCO Invitrogen Corporation, Gran Island, NY, USA). Cells were pooled, centrifuged at 700 g for 5 min and seeded at a density of 1,000 cells/cm2. After the third passage, BM-hMSCs were harvested.","total RNA","RNAs were isolated using the miRNeasy mini kit (Qiagen) protocol following the manufacturer's instructions","Cy3","Agilent Two Color Quick Amp Labeling and RNA Spike-In kits protocols following the manufacturer's instructions","9606","Test sample: mock-treated bone marrow-derived mesenchymal stromal cells sample M41-P3","Homo sapiens","tissue: Bone marrow-derived mesenchymal stromal cells sample M41-P3","agent: mock","Five million detached BM-hMSCs were concentrated at 30 x 106 cells/ml in HBSS, without Ca2+ or Mg2+ (Gibco), containing 10 mM HEPES, 0.1 % human serum albumin (Sigma-Aldrich). Each sample was divided into two reaction tubes, buffer alone, and the other with 60 mU/ml of FTVI or FTVII (obtained from R&D Systems), as specified in each case, containing  1 mM GDP-fucose (Sigma-Aldrich) as enzyme substrate. Reactions were performed at 37 oC for 1 h with gentle shaking, followed by centrifugation and washing with DPBS.","BM mononuclear cells (BMMNC) were isolated by density gradient centrifugation over Histopaque-1077 (Sigma-Aldrich, St Louis, MO).  Human Platelet Lysate was obtained from platelet concentrates, which were frozen at –80 ºC for at least 3 days, thawed at 37 oC, transferred to sterile tubes and centrifuged at 900 g for 30 min; the supernatants were pooled, aliquoted and stored at –20ºC. BMMNC were seeded in culture flasks at 160,000 cells/cm2 using low glucose DMEM (GIBCO Invitrogen Corporation, Gran Island, NY, USA) supplemented with 5 % HPL, plus 50 U/ml penicillin and 50 U/ml streptomycin, and heparin (2U/ml) incubated at 37oC in a humid atmosphere with 5 % CO2. First change of medium was performed at 24 h and from this point twice per week. First passage was made when cells achieved 60-80% confluence. Culture media was removed and culture flasks were washed with DPBS, then incubated with TrypLE Select reagent (GIBCO Invitrogen Corporation, Gran Island, NY, USA). Cells were pooled, centrifuged at 700 g for 5 min and seeded at a density of 1,000 cells/cm2. After the third passage, BM-hMSCs were harvested.","total RNA","RNAs were isolated using the miRNeasy mini kit (Qiagen) protocol following the manufacturer's instructions","Cy5","Agilent Two Color Quick Amp Labeling and RNA Spike-In kits protocols following the manufacturer's instructions","9606","Agilent Gene Expression Hybridization kit protocol following the manufacturer's instructions","Agilent G2565CA scanner, Agilent Scan Control software, scanning at 3µm","Agilent Feature Extraction software version 11.0.1.1","GPL16699","Antonio,,Parrado","antonio.parrado@carm.es","Hospital Clinico Universitario Virgen de la Arrixaca","Ctra. Madrid-Cartagena, s/n","Murcia","30120","Spain","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2399nnn/GSM2399032/suppl/GSM2399032_06C_M41-P3.txt.gz","62976","none","mock","Bone marrow-derived mesenchymal stromal cells","Bone marrow-derived mesenchymal stromal cells sample M41-P3"
"FTVI-treated BMSC sample M41-P3","GSM2399033","Public on Sep 05 2018","Nov 22 2016","Sep 05 2018","RNA","2","Reference sample: pool of 5 samples of bone marrow-derived mesenchymal stromal cells","Homo sapiens","tissue: Bone marrow-derived mesenchymal stromal cells","agent: none","Five million detached BM-hMSCs were concentrated at 30 x 106 cells/ml in HBSS, without Ca2+ or Mg2+ (Gibco), containing 10 mM HEPES, 0.1 % human serum albumin (Sigma-Aldrich). Each sample was divided into two reaction tubes, buffer alone, and the other with 60 mU/ml of FTVI or FTVII (obtained from R&D Systems), as specified in each case, containing  1 mM GDP-fucose (Sigma-Aldrich) as enzyme substrate. Reactions were performed at 37 oC for 1 h with gentle shaking, followed by centrifugation and washing with DPBS.","BM mononuclear cells (BMMNC) were isolated by density gradient centrifugation over Histopaque-1077 (Sigma-Aldrich, St Louis, MO).  Human Platelet Lysate was obtained from platelet concentrates, which were frozen at –80 ºC for at least 3 days, thawed at 37 oC, transferred to sterile tubes and centrifuged at 900 g for 30 min; the supernatants were pooled, aliquoted and stored at –20ºC. BMMNC were seeded in culture flasks at 160,000 cells/cm2 using low glucose DMEM (GIBCO Invitrogen Corporation, Gran Island, NY, USA) supplemented with 5 % HPL, plus 50 U/ml penicillin and 50 U/ml streptomycin, and heparin (2U/ml) incubated at 37oC in a humid atmosphere with 5 % CO2. First change of medium was performed at 24 h and from this point twice per week. First passage was made when cells achieved 60-80% confluence. Culture media was removed and culture flasks were washed with DPBS, then incubated with TrypLE Select reagent (GIBCO Invitrogen Corporation, Gran Island, NY, USA). Cells were pooled, centrifuged at 700 g for 5 min and seeded at a density of 1,000 cells/cm2. After the third passage, BM-hMSCs were harvested.","total RNA","RNAs were isolated using the miRNeasy mini kit (Qiagen) protocol following the manufacturer's instructions","Cy3","Agilent Two Color Quick Amp Labeling and RNA Spike-In kits protocols following the manufacturer's instructions","9606","Test sample: FTVI-treated bone marrow-derived mesenchymal stromal cells sample M41-P3","Homo sapiens","tissue: Bone marrow-derived mesenchymal stromal cells sample M41-P3","agent: FTVI","Five million detached BM-hMSCs were concentrated at 30 x 106 cells/ml in HBSS, without Ca2+ or Mg2+ (Gibco), containing 10 mM HEPES, 0.1 % human serum albumin (Sigma-Aldrich). Each sample was divided into two reaction tubes, buffer alone, and the other with 60 mU/ml of FTVI or FTVII (obtained from R&D Systems), as specified in each case, containing  1 mM GDP-fucose (Sigma-Aldrich) as enzyme substrate. Reactions were performed at 37 oC for 1 h with gentle shaking, followed by centrifugation and washing with DPBS.","BM mononuclear cells (BMMNC) were isolated by density gradient centrifugation over Histopaque-1077 (Sigma-Aldrich, St Louis, MO).  Human Platelet Lysate was obtained from platelet concentrates, which were frozen at –80 ºC for at least 3 days, thawed at 37 oC, transferred to sterile tubes and centrifuged at 900 g for 30 min; the supernatants were pooled, aliquoted and stored at –20ºC. BMMNC were seeded in culture flasks at 160,000 cells/cm2 using low glucose DMEM (GIBCO Invitrogen Corporation, Gran Island, NY, USA) supplemented with 5 % HPL, plus 50 U/ml penicillin and 50 U/ml streptomycin, and heparin (2U/ml) incubated at 37oC in a humid atmosphere with 5 % CO2. First change of medium was performed at 24 h and from this point twice per week. First passage was made when cells achieved 60-80% confluence. Culture media was removed and culture flasks were washed with DPBS, then incubated with TrypLE Select reagent (GIBCO Invitrogen Corporation, Gran Island, NY, USA). Cells were pooled, centrifuged at 700 g for 5 min and seeded at a density of 1,000 cells/cm2. After the third passage, BM-hMSCs were harvested.","total RNA","RNAs were isolated using the miRNeasy mini kit (Qiagen) protocol following the manufacturer's instructions","Cy5","Agilent Two Color Quick Amp Labeling and RNA Spike-In kits protocols following the manufacturer's instructions","9606","Agilent Gene Expression Hybridization kit protocol following the manufacturer's instructions","Agilent G2565CA scanner, Agilent Scan Control software, scanning at 3µm","Agilent Feature Extraction software version 11.0.1.1","GPL16699","Antonio,,Parrado","antonio.parrado@carm.es","Hospital Clinico Universitario Virgen de la Arrixaca","Ctra. Madrid-Cartagena, s/n","Murcia","30120","Spain","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2399nnn/GSM2399033/suppl/GSM2399033_06F_M41-P3.txt.gz","62976","none","FTVI","Bone marrow-derived mesenchymal stromal cells","Bone marrow-derived mesenchymal stromal cells sample M41-P3"
"Mock-treated BMSC sample RP-003-P2","GSM2399034","Public on Sep 05 2018","Nov 22 2016","Sep 05 2018","RNA","2","Reference sample: pool of 5 samples of bone marrow-derived mesenchymal stromal cells","Homo sapiens","tissue: Bone marrow-derived mesenchymal stromal cells","agent: none","Five million detached BM-hMSCs were concentrated at 30 x 106 cells/ml in HBSS, without Ca2+ or Mg2+ (Gibco), containing 10 mM HEPES, 0.1 % human serum albumin (Sigma-Aldrich). Each sample was divided into two reaction tubes, buffer alone, and the other with 60 mU/ml of FTVI or FTVII (obtained from R&D Systems), as specified in each case, containing  1 mM GDP-fucose (Sigma-Aldrich) as enzyme substrate. Reactions were performed at 37 oC for 1 h with gentle shaking, followed by centrifugation and washing with DPBS.","BM mononuclear cells (BMMNC) were isolated by density gradient centrifugation over Histopaque-1077 (Sigma-Aldrich, St Louis, MO).  Human Platelet Lysate was obtained from platelet concentrates, which were frozen at –80 ºC for at least 3 days, thawed at 37 oC, transferred to sterile tubes and centrifuged at 900 g for 30 min; the supernatants were pooled, aliquoted and stored at –20ºC. BMMNC were seeded in culture flasks at 160,000 cells/cm2 using low glucose DMEM (GIBCO Invitrogen Corporation, Gran Island, NY, USA) supplemented with 5 % HPL, plus 50 U/ml penicillin and 50 U/ml streptomycin, and heparin (2U/ml) incubated at 37oC in a humid atmosphere with 5 % CO2. First change of medium was performed at 24 h and from this point twice per week. First passage was made when cells achieved 60-80% confluence. Culture media was removed and culture flasks were washed with DPBS, then incubated with TrypLE Select reagent (GIBCO Invitrogen Corporation, Gran Island, NY, USA). Cells were pooled, centrifuged at 700 g for 5 min and seeded at a density of 1,000 cells/cm2. After the third passage, BM-hMSCs were harvested.","total RNA","RNAs were isolated using the miRNeasy mini kit (Qiagen) protocol following the manufacturer's instructions","Cy3","Agilent Two Color Quick Amp Labeling and RNA Spike-In kits protocols following the manufacturer's instructions","9606","Test sample: mock-treated bone marrow-derived mesenchymal stromal cells sample RP-003-P2","Homo sapiens","tissue: Bone marrow-derived mesenchymal stromal cells sample RP-003-P2","agent: mock","Five million detached BM-hMSCs were concentrated at 30 x 106 cells/ml in HBSS, without Ca2+ or Mg2+ (Gibco), containing 10 mM HEPES, 0.1 % human serum albumin (Sigma-Aldrich). Each sample was divided into two reaction tubes, buffer alone, and the other with 60 mU/ml of FTVI or FTVII (obtained from R&D Systems), as specified in each case, containing  1 mM GDP-fucose (Sigma-Aldrich) as enzyme substrate. Reactions were performed at 37 oC for 1 h with gentle shaking, followed by centrifugation and washing with DPBS.","BM mononuclear cells (BMMNC) were isolated by density gradient centrifugation over Histopaque-1077 (Sigma-Aldrich, St Louis, MO).  Human Platelet Lysate was obtained from platelet concentrates, which were frozen at –80 ºC for at least 3 days, thawed at 37 oC, transferred to sterile tubes and centrifuged at 900 g for 30 min; the supernatants were pooled, aliquoted and stored at –20ºC. BMMNC were seeded in culture flasks at 160,000 cells/cm2 using low glucose DMEM (GIBCO Invitrogen Corporation, Gran Island, NY, USA) supplemented with 5 % HPL, plus 50 U/ml penicillin and 50 U/ml streptomycin, and heparin (2U/ml) incubated at 37oC in a humid atmosphere with 5 % CO2. First change of medium was performed at 24 h and from this point twice per week. First passage was made when cells achieved 60-80% confluence. Culture media was removed and culture flasks were washed with DPBS, then incubated with TrypLE Select reagent (GIBCO Invitrogen Corporation, Gran Island, NY, USA). Cells were pooled, centrifuged at 700 g for 5 min and seeded at a density of 1,000 cells/cm2. After the third passage, BM-hMSCs were harvested.","total RNA","RNAs were isolated using the miRNeasy mini kit (Qiagen) protocol following the manufacturer's instructions","Cy5","Agilent Two Color Quick Amp Labeling and RNA Spike-In kits protocols following the manufacturer's instructions","9606","Agilent Gene Expression Hybridization kit protocol following the manufacturer's instructions","Agilent G2565CA scanner, Agilent Scan Control software, scanning at 3µm","Agilent Feature Extraction software version 11.0.1.1","GPL16699","Antonio,,Parrado","antonio.parrado@carm.es","Hospital Clinico Universitario Virgen de la Arrixaca","Ctra. Madrid-Cartagena, s/n","Murcia","30120","Spain","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2399nnn/GSM2399034/suppl/GSM2399034_07C_RP-003-P2.txt.gz","62976","none","mock","Bone marrow-derived mesenchymal stromal cells","Bone marrow-derived mesenchymal stromal cells sample RP-003-P2"
"FTVI-treated BMSC sample RP-003-P2","GSM2399035","Public on Sep 05 2018","Nov 22 2016","Sep 05 2018","RNA","2","Reference sample: pool of 5 samples of bone marrow-derived mesenchymal stromal cells","Homo sapiens","tissue: Bone marrow-derived mesenchymal stromal cells","agent: none","Five million detached BM-hMSCs were concentrated at 30 x 106 cells/ml in HBSS, without Ca2+ or Mg2+ (Gibco), containing 10 mM HEPES, 0.1 % human serum albumin (Sigma-Aldrich). Each sample was divided into two reaction tubes, buffer alone, and the other with 60 mU/ml of FTVI or FTVII (obtained from R&D Systems), as specified in each case, containing  1 mM GDP-fucose (Sigma-Aldrich) as enzyme substrate. Reactions were performed at 37 oC for 1 h with gentle shaking, followed by centrifugation and washing with DPBS.","BM mononuclear cells (BMMNC) were isolated by density gradient centrifugation over Histopaque-1077 (Sigma-Aldrich, St Louis, MO).  Human Platelet Lysate was obtained from platelet concentrates, which were frozen at –80 ºC for at least 3 days, thawed at 37 oC, transferred to sterile tubes and centrifuged at 900 g for 30 min; the supernatants were pooled, aliquoted and stored at –20ºC. BMMNC were seeded in culture flasks at 160,000 cells/cm2 using low glucose DMEM (GIBCO Invitrogen Corporation, Gran Island, NY, USA) supplemented with 5 % HPL, plus 50 U/ml penicillin and 50 U/ml streptomycin, and heparin (2U/ml) incubated at 37oC in a humid atmosphere with 5 % CO2. First change of medium was performed at 24 h and from this point twice per week. First passage was made when cells achieved 60-80% confluence. Culture media was removed and culture flasks were washed with DPBS, then incubated with TrypLE Select reagent (GIBCO Invitrogen Corporation, Gran Island, NY, USA). Cells were pooled, centrifuged at 700 g for 5 min and seeded at a density of 1,000 cells/cm2. After the third passage, BM-hMSCs were harvested.","total RNA","RNAs were isolated using the miRNeasy mini kit (Qiagen) protocol following the manufacturer's instructions","Cy3","Agilent Two Color Quick Amp Labeling and RNA Spike-In kits protocols following the manufacturer's instructions","9606","Test sample: FTVI-treated bone marrow-derived mesenchymal stromal cells sample RP-003-P2","Homo sapiens","tissue: Bone marrow-derived mesenchymal stromal cells sample RP-003-P2","agent: FTVI","Five million detached BM-hMSCs were concentrated at 30 x 106 cells/ml in HBSS, without Ca2+ or Mg2+ (Gibco), containing 10 mM HEPES, 0.1 % human serum albumin (Sigma-Aldrich). Each sample was divided into two reaction tubes, buffer alone, and the other with 60 mU/ml of FTVI or FTVII (obtained from R&D Systems), as specified in each case, containing  1 mM GDP-fucose (Sigma-Aldrich) as enzyme substrate. Reactions were performed at 37 oC for 1 h with gentle shaking, followed by centrifugation and washing with DPBS.","BM mononuclear cells (BMMNC) were isolated by density gradient centrifugation over Histopaque-1077 (Sigma-Aldrich, St Louis, MO).  Human Platelet Lysate was obtained from platelet concentrates, which were frozen at –80 ºC for at least 3 days, thawed at 37 oC, transferred to sterile tubes and centrifuged at 900 g for 30 min; the supernatants were pooled, aliquoted and stored at –20ºC. BMMNC were seeded in culture flasks at 160,000 cells/cm2 using low glucose DMEM (GIBCO Invitrogen Corporation, Gran Island, NY, USA) supplemented with 5 % HPL, plus 50 U/ml penicillin and 50 U/ml streptomycin, and heparin (2U/ml) incubated at 37oC in a humid atmosphere with 5 % CO2. First change of medium was performed at 24 h and from this point twice per week. First passage was made when cells achieved 60-80% confluence. Culture media was removed and culture flasks were washed with DPBS, then incubated with TrypLE Select reagent (GIBCO Invitrogen Corporation, Gran Island, NY, USA). Cells were pooled, centrifuged at 700 g for 5 min and seeded at a density of 1,000 cells/cm2. After the third passage, BM-hMSCs were harvested.","total RNA","RNAs were isolated using the miRNeasy mini kit (Qiagen) protocol following the manufacturer's instructions","Cy5","Agilent Two Color Quick Amp Labeling and RNA Spike-In kits protocols following the manufacturer's instructions","9606","Agilent Gene Expression Hybridization kit protocol following the manufacturer's instructions","Agilent G2565CA scanner, Agilent Scan Control software, scanning at 3µm","Agilent Feature Extraction software version 11.0.1.1","GPL16699","Antonio,,Parrado","antonio.parrado@carm.es","Hospital Clinico Universitario Virgen de la Arrixaca","Ctra. Madrid-Cartagena, s/n","Murcia","30120","Spain","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2399nnn/GSM2399035/suppl/GSM2399035_07F_RP-003-P2.txt.gz","62976","none","FTVI","Bone marrow-derived mesenchymal stromal cells","Bone marrow-derived mesenchymal stromal cells sample RP-003-P2"
"Mock-treated BMSC sample OSP-V002-P2","GSM2399036","Public on Sep 05 2018","Nov 22 2016","Sep 05 2018","RNA","2","Reference sample: pool of 5 samples of bone marrow-derived mesenchymal stromal cells","Homo sapiens","tissue: Bone marrow-derived mesenchymal stromal cells","agent: none","Five million detached BM-hMSCs were concentrated at 30 x 106 cells/ml in HBSS, without Ca2+ or Mg2+ (Gibco), containing 10 mM HEPES, 0.1 % human serum albumin (Sigma-Aldrich). Each sample was divided into two reaction tubes, buffer alone, and the other with 60 mU/ml of FTVI or FTVII (obtained from R&D Systems), as specified in each case, containing  1 mM GDP-fucose (Sigma-Aldrich) as enzyme substrate. Reactions were performed at 37 oC for 1 h with gentle shaking, followed by centrifugation and washing with DPBS.","BM mononuclear cells (BMMNC) were isolated by density gradient centrifugation over Histopaque-1077 (Sigma-Aldrich, St Louis, MO).  Human Platelet Lysate was obtained from platelet concentrates, which were frozen at –80 ºC for at least 3 days, thawed at 37 oC, transferred to sterile tubes and centrifuged at 900 g for 30 min; the supernatants were pooled, aliquoted and stored at –20ºC. BMMNC were seeded in culture flasks at 160,000 cells/cm2 using low glucose DMEM (GIBCO Invitrogen Corporation, Gran Island, NY, USA) supplemented with 5 % HPL, plus 50 U/ml penicillin and 50 U/ml streptomycin, and heparin (2U/ml) incubated at 37oC in a humid atmosphere with 5 % CO2. First change of medium was performed at 24 h and from this point twice per week. First passage was made when cells achieved 60-80% confluence. Culture media was removed and culture flasks were washed with DPBS, then incubated with TrypLE Select reagent (GIBCO Invitrogen Corporation, Gran Island, NY, USA). Cells were pooled, centrifuged at 700 g for 5 min and seeded at a density of 1,000 cells/cm2. After the third passage, BM-hMSCs were harvested.","total RNA","RNAs were isolated using the miRNeasy mini kit (Qiagen) protocol following the manufacturer's instructions","Cy3","Agilent Two Color Quick Amp Labeling and RNA Spike-In kits protocols following the manufacturer's instructions","9606","Test sample: mock-treated bone marrow-derived mesenchymal stromal cells sample OSP_V002-P2","Homo sapiens","tissue: Bone marrow-derived mesenchymal stromal cells sample OSP_V002-P2","agent: mock","Five million detached BM-hMSCs were concentrated at 30 x 106 cells/ml in HBSS, without Ca2+ or Mg2+ (Gibco), containing 10 mM HEPES, 0.1 % human serum albumin (Sigma-Aldrich). Each sample was divided into two reaction tubes, buffer alone, and the other with 60 mU/ml of FTVI or FTVII (obtained from R&D Systems), as specified in each case, containing  1 mM GDP-fucose (Sigma-Aldrich) as enzyme substrate. Reactions were performed at 37 oC for 1 h with gentle shaking, followed by centrifugation and washing with DPBS.","BM mononuclear cells (BMMNC) were isolated by density gradient centrifugation over Histopaque-1077 (Sigma-Aldrich, St Louis, MO).  Human Platelet Lysate was obtained from platelet concentrates, which were frozen at –80 ºC for at least 3 days, thawed at 37 oC, transferred to sterile tubes and centrifuged at 900 g for 30 min; the supernatants were pooled, aliquoted and stored at –20ºC. BMMNC were seeded in culture flasks at 160,000 cells/cm2 using low glucose DMEM (GIBCO Invitrogen Corporation, Gran Island, NY, USA) supplemented with 5 % HPL, plus 50 U/ml penicillin and 50 U/ml streptomycin, and heparin (2U/ml) incubated at 37oC in a humid atmosphere with 5 % CO2. First change of medium was performed at 24 h and from this point twice per week. First passage was made when cells achieved 60-80% confluence. Culture media was removed and culture flasks were washed with DPBS, then incubated with TrypLE Select reagent (GIBCO Invitrogen Corporation, Gran Island, NY, USA). Cells were pooled, centrifuged at 700 g for 5 min and seeded at a density of 1,000 cells/cm2. After the third passage, BM-hMSCs were harvested.","total RNA","RNAs were isolated using the miRNeasy mini kit (Qiagen) protocol following the manufacturer's instructions","Cy5","Agilent Two Color Quick Amp Labeling and RNA Spike-In kits protocols following the manufacturer's instructions","9606","Agilent Gene Expression Hybridization kit protocol following the manufacturer's instructions","Agilent G2565CA scanner, Agilent Scan Control software, scanning at 3µm","Agilent Feature Extraction software version 11.0.1.1","GPL16699","Antonio,,Parrado","antonio.parrado@carm.es","Hospital Clinico Universitario Virgen de la Arrixaca","Ctra. Madrid-Cartagena, s/n","Murcia","30120","Spain","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2399nnn/GSM2399036/suppl/GSM2399036_11C_OSP_V002-P2.txt.gz","62976","none","mock","Bone marrow-derived mesenchymal stromal cells","Bone marrow-derived mesenchymal stromal cells sample OSP_V002-P2"
"FTVII-treated BMSC sample OSP-V002-P2","GSM2399037","Public on Sep 05 2018","Nov 22 2016","Sep 05 2018","RNA","2","Reference sample: pool of 5 samples of bone marrow-derived mesenchymal stromal cells","Homo sapiens","tissue: Bone marrow-derived mesenchymal stromal cells","agent: none","Five million detached BM-hMSCs were concentrated at 30 x 106 cells/ml in HBSS, without Ca2+ or Mg2+ (Gibco), containing 10 mM HEPES, 0.1 % human serum albumin (Sigma-Aldrich). Each sample was divided into two reaction tubes, buffer alone, and the other with 60 mU/ml of FTVI or FTVII (obtained from R&D Systems), as specified in each case, containing  1 mM GDP-fucose (Sigma-Aldrich) as enzyme substrate. Reactions were performed at 37 oC for 1 h with gentle shaking, followed by centrifugation and washing with DPBS.","BM mononuclear cells (BMMNC) were isolated by density gradient centrifugation over Histopaque-1077 (Sigma-Aldrich, St Louis, MO).  Human Platelet Lysate was obtained from platelet concentrates, which were frozen at –80 ºC for at least 3 days, thawed at 37 oC, transferred to sterile tubes and centrifuged at 900 g for 30 min; the supernatants were pooled, aliquoted and stored at –20ºC. BMMNC were seeded in culture flasks at 160,000 cells/cm2 using low glucose DMEM (GIBCO Invitrogen Corporation, Gran Island, NY, USA) supplemented with 5 % HPL, plus 50 U/ml penicillin and 50 U/ml streptomycin, and heparin (2U/ml) incubated at 37oC in a humid atmosphere with 5 % CO2. First change of medium was performed at 24 h and from this point twice per week. First passage was made when cells achieved 60-80% confluence. Culture media was removed and culture flasks were washed with DPBS, then incubated with TrypLE Select reagent (GIBCO Invitrogen Corporation, Gran Island, NY, USA). Cells were pooled, centrifuged at 700 g for 5 min and seeded at a density of 1,000 cells/cm2. After the third passage, BM-hMSCs were harvested.","total RNA","RNAs were isolated using the miRNeasy mini kit (Qiagen) protocol following the manufacturer's instructions","Cy3","Agilent Two Color Quick Amp Labeling and RNA Spike-In kits protocols following the manufacturer's instructions","9606","Test sample: FTVII-treated bone marrow-derived mesenchymal stromal cells sample OSP_V002-P2","Homo sapiens","tissue: Bone marrow-derived mesenchymal stromal cells sample OSP_V002-P2","agent: FTVII","Five million detached BM-hMSCs were concentrated at 30 x 106 cells/ml in HBSS, without Ca2+ or Mg2+ (Gibco), containing 10 mM HEPES, 0.1 % human serum albumin (Sigma-Aldrich). Each sample was divided into two reaction tubes, buffer alone, and the other with 60 mU/ml of FTVI or FTVII (obtained from R&D Systems), as specified in each case, containing  1 mM GDP-fucose (Sigma-Aldrich) as enzyme substrate. Reactions were performed at 37 oC for 1 h with gentle shaking, followed by centrifugation and washing with DPBS.","BM mononuclear cells (BMMNC) were isolated by density gradient centrifugation over Histopaque-1077 (Sigma-Aldrich, St Louis, MO).  Human Platelet Lysate was obtained from platelet concentrates, which were frozen at –80 ºC for at least 3 days, thawed at 37 oC, transferred to sterile tubes and centrifuged at 900 g for 30 min; the supernatants were pooled, aliquoted and stored at –20ºC. BMMNC were seeded in culture flasks at 160,000 cells/cm2 using low glucose DMEM (GIBCO Invitrogen Corporation, Gran Island, NY, USA) supplemented with 5 % HPL, plus 50 U/ml penicillin and 50 U/ml streptomycin, and heparin (2U/ml) incubated at 37oC in a humid atmosphere with 5 % CO2. First change of medium was performed at 24 h and from this point twice per week. First passage was made when cells achieved 60-80% confluence. Culture media was removed and culture flasks were washed with DPBS, then incubated with TrypLE Select reagent (GIBCO Invitrogen Corporation, Gran Island, NY, USA). Cells were pooled, centrifuged at 700 g for 5 min and seeded at a density of 1,000 cells/cm2. After the third passage, BM-hMSCs were harvested.","total RNA","RNAs were isolated using the miRNeasy mini kit (Qiagen) protocol following the manufacturer's instructions","Cy5","Agilent Two Color Quick Amp Labeling and RNA Spike-In kits protocols following the manufacturer's instructions","9606","Agilent Gene Expression Hybridization kit protocol following the manufacturer's instructions","Agilent G2565CA scanner, Agilent Scan Control software, scanning at 3µm","Agilent Feature Extraction software version 11.0.1.1","GPL16699","Antonio,,Parrado","antonio.parrado@carm.es","Hospital Clinico Universitario Virgen de la Arrixaca","Ctra. Madrid-Cartagena, s/n","Murcia","30120","Spain","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2399nnn/GSM2399037/suppl/GSM2399037_11F_OSP_V002-P2.txt.gz","62976","none","FTVII","Bone marrow-derived mesenchymal stromal cells","Bone marrow-derived mesenchymal stromal cells sample OSP_V002-P2"
"Mock-treated BMSC sample OSP-V001","GSM2399038","Public on Sep 05 2018","Nov 22 2016","Sep 05 2018","RNA","2","Reference sample: pool of 5 samples of bone marrow-derived mesenchymal stromal cells","Homo sapiens","tissue: Bone marrow-derived mesenchymal stromal cells","agent: none","Five million detached BM-hMSCs were concentrated at 30 x 106 cells/ml in HBSS, without Ca2+ or Mg2+ (Gibco), containing 10 mM HEPES, 0.1 % human serum albumin (Sigma-Aldrich). Each sample was divided into two reaction tubes, buffer alone, and the other with 60 mU/ml of FTVI or FTVII (obtained from R&D Systems), as specified in each case, containing  1 mM GDP-fucose (Sigma-Aldrich) as enzyme substrate. Reactions were performed at 37 oC for 1 h with gentle shaking, followed by centrifugation and washing with DPBS.","BM mononuclear cells (BMMNC) were isolated by density gradient centrifugation over Histopaque-1077 (Sigma-Aldrich, St Louis, MO).  Human Platelet Lysate was obtained from platelet concentrates, which were frozen at –80 ºC for at least 3 days, thawed at 37 oC, transferred to sterile tubes and centrifuged at 900 g for 30 min; the supernatants were pooled, aliquoted and stored at –20ºC. BMMNC were seeded in culture flasks at 160,000 cells/cm2 using low glucose DMEM (GIBCO Invitrogen Corporation, Gran Island, NY, USA) supplemented with 5 % HPL, plus 50 U/ml penicillin and 50 U/ml streptomycin, and heparin (2U/ml) incubated at 37oC in a humid atmosphere with 5 % CO2. First change of medium was performed at 24 h and from this point twice per week. First passage was made when cells achieved 60-80% confluence. Culture media was removed and culture flasks were washed with DPBS, then incubated with TrypLE Select reagent (GIBCO Invitrogen Corporation, Gran Island, NY, USA). Cells were pooled, centrifuged at 700 g for 5 min and seeded at a density of 1,000 cells/cm2. After the third passage, BM-hMSCs were harvested.","total RNA","RNAs were isolated using the miRNeasy mini kit (Qiagen) protocol following the manufacturer's instructions","Cy3","Agilent Two Color Quick Amp Labeling and RNA Spike-In kits protocols following the manufacturer's instructions","9606","Test sample: mock-treated bone marrow-derived mesenchymal stromal cells sample OSP_V001","Homo sapiens","tissue: Bone marrow-derived mesenchymal stromal cells sample OSP_V001","agent: mock","Five million detached BM-hMSCs were concentrated at 30 x 106 cells/ml in HBSS, without Ca2+ or Mg2+ (Gibco), containing 10 mM HEPES, 0.1 % human serum albumin (Sigma-Aldrich). Each sample was divided into two reaction tubes, buffer alone, and the other with 60 mU/ml of FTVI or FTVII (obtained from R&D Systems), as specified in each case, containing  1 mM GDP-fucose (Sigma-Aldrich) as enzyme substrate. Reactions were performed at 37 oC for 1 h with gentle shaking, followed by centrifugation and washing with DPBS.","BM mononuclear cells (BMMNC) were isolated by density gradient centrifugation over Histopaque-1077 (Sigma-Aldrich, St Louis, MO).  Human Platelet Lysate was obtained from platelet concentrates, which were frozen at –80 ºC for at least 3 days, thawed at 37 oC, transferred to sterile tubes and centrifuged at 900 g for 30 min; the supernatants were pooled, aliquoted and stored at –20ºC. BMMNC were seeded in culture flasks at 160,000 cells/cm2 using low glucose DMEM (GIBCO Invitrogen Corporation, Gran Island, NY, USA) supplemented with 5 % HPL, plus 50 U/ml penicillin and 50 U/ml streptomycin, and heparin (2U/ml) incubated at 37oC in a humid atmosphere with 5 % CO2. First change of medium was performed at 24 h and from this point twice per week. First passage was made when cells achieved 60-80% confluence. Culture media was removed and culture flasks were washed with DPBS, then incubated with TrypLE Select reagent (GIBCO Invitrogen Corporation, Gran Island, NY, USA). Cells were pooled, centrifuged at 700 g for 5 min and seeded at a density of 1,000 cells/cm2. After the third passage, BM-hMSCs were harvested.","total RNA","RNAs were isolated using the miRNeasy mini kit (Qiagen) protocol following the manufacturer's instructions","Cy5","Agilent Two Color Quick Amp Labeling and RNA Spike-In kits protocols following the manufacturer's instructions","9606","Agilent Gene Expression Hybridization kit protocol following the manufacturer's instructions","Agilent G2565CA scanner, Agilent Scan Control software, scanning at 3µm","Agilent Feature Extraction software version 11.0.1.1","GPL16699","Antonio,,Parrado","antonio.parrado@carm.es","Hospital Clinico Universitario Virgen de la Arrixaca","Ctra. Madrid-Cartagena, s/n","Murcia","30120","Spain","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2399nnn/GSM2399038/suppl/GSM2399038_12C_OSP_V001.txt.gz","62976","none","mock","Bone marrow-derived mesenchymal stromal cells","Bone marrow-derived mesenchymal stromal cells sample OSP_V001"
"FTVII-treated BMSC sample OSP-V001","GSM2399039","Public on Sep 05 2018","Nov 22 2016","Sep 05 2018","RNA","2","Reference sample: pool of 5 samples of bone marrow-derived mesenchymal stromal cells","Homo sapiens","tissue: Bone marrow-derived mesenchymal stromal cells","agent: none","Five million detached BM-hMSCs were concentrated at 30 x 106 cells/ml in HBSS, without Ca2+ or Mg2+ (Gibco), containing 10 mM HEPES, 0.1 % human serum albumin (Sigma-Aldrich). Each sample was divided into two reaction tubes, buffer alone, and the other with 60 mU/ml of FTVI or FTVII (obtained from R&D Systems), as specified in each case, containing  1 mM GDP-fucose (Sigma-Aldrich) as enzyme substrate. Reactions were performed at 37 oC for 1 h with gentle shaking, followed by centrifugation and washing with DPBS.","BM mononuclear cells (BMMNC) were isolated by density gradient centrifugation over Histopaque-1077 (Sigma-Aldrich, St Louis, MO).  Human Platelet Lysate was obtained from platelet concentrates, which were frozen at –80 ºC for at least 3 days, thawed at 37 oC, transferred to sterile tubes and centrifuged at 900 g for 30 min; the supernatants were pooled, aliquoted and stored at –20ºC. BMMNC were seeded in culture flasks at 160,000 cells/cm2 using low glucose DMEM (GIBCO Invitrogen Corporation, Gran Island, NY, USA) supplemented with 5 % HPL, plus 50 U/ml penicillin and 50 U/ml streptomycin, and heparin (2U/ml) incubated at 37oC in a humid atmosphere with 5 % CO2. First change of medium was performed at 24 h and from this point twice per week. First passage was made when cells achieved 60-80% confluence. Culture media was removed and culture flasks were washed with DPBS, then incubated with TrypLE Select reagent (GIBCO Invitrogen Corporation, Gran Island, NY, USA). Cells were pooled, centrifuged at 700 g for 5 min and seeded at a density of 1,000 cells/cm2. After the third passage, BM-hMSCs were harvested.","total RNA","RNAs were isolated using the miRNeasy mini kit (Qiagen) protocol following the manufacturer's instructions","Cy3","Agilent Two Color Quick Amp Labeling and RNA Spike-In kits protocols following the manufacturer's instructions","9606","Test sample: FTVII-treated bone marrow-derived mesenchymal stromal cells sample OSP_V001","Homo sapiens","tissue: Bone marrow-derived mesenchymal stromal cells sample OSP_V001","agent: FTVII","Five million detached BM-hMSCs were concentrated at 30 x 106 cells/ml in HBSS, without Ca2+ or Mg2+ (Gibco), containing 10 mM HEPES, 0.1 % human serum albumin (Sigma-Aldrich). Each sample was divided into two reaction tubes, buffer alone, and the other with 60 mU/ml of FTVI or FTVII (obtained from R&D Systems), as specified in each case, containing  1 mM GDP-fucose (Sigma-Aldrich) as enzyme substrate. Reactions were performed at 37 oC for 1 h with gentle shaking, followed by centrifugation and washing with DPBS.","BM mononuclear cells (BMMNC) were isolated by density gradient centrifugation over Histopaque-1077 (Sigma-Aldrich, St Louis, MO).  Human Platelet Lysate was obtained from platelet concentrates, which were frozen at –80 ºC for at least 3 days, thawed at 37 oC, transferred to sterile tubes and centrifuged at 900 g for 30 min; the supernatants were pooled, aliquoted and stored at –20ºC. BMMNC were seeded in culture flasks at 160,000 cells/cm2 using low glucose DMEM (GIBCO Invitrogen Corporation, Gran Island, NY, USA) supplemented with 5 % HPL, plus 50 U/ml penicillin and 50 U/ml streptomycin, and heparin (2U/ml) incubated at 37oC in a humid atmosphere with 5 % CO2. First change of medium was performed at 24 h and from this point twice per week. First passage was made when cells achieved 60-80% confluence. Culture media was removed and culture flasks were washed with DPBS, then incubated with TrypLE Select reagent (GIBCO Invitrogen Corporation, Gran Island, NY, USA). Cells were pooled, centrifuged at 700 g for 5 min and seeded at a density of 1,000 cells/cm2. After the third passage, BM-hMSCs were harvested.","total RNA","RNAs were isolated using the miRNeasy mini kit (Qiagen) protocol following the manufacturer's instructions","Cy5","Agilent Two Color Quick Amp Labeling and RNA Spike-In kits protocols following the manufacturer's instructions","9606","Agilent Gene Expression Hybridization kit protocol following the manufacturer's instructions","Agilent G2565CA scanner, Agilent Scan Control software, scanning at 3µm","Agilent Feature Extraction software version 11.0.1.1","GPL16699","Antonio,,Parrado","antonio.parrado@carm.es","Hospital Clinico Universitario Virgen de la Arrixaca","Ctra. Madrid-Cartagena, s/n","Murcia","30120","Spain","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2399nnn/GSM2399039/suppl/GSM2399039_12F_OSP_V001.txt.gz","62976","none","FTVII","Bone marrow-derived mesenchymal stromal cells","Bone marrow-derived mesenchymal stromal cells sample OSP_V001"
"Mock-treated BMSC sample OSP-V001-P3","GSM2399040","Public on Sep 05 2018","Nov 22 2016","Sep 05 2018","RNA","2","Reference sample: pool of 5 samples of bone marrow-derived mesenchymal stromal cells","Homo sapiens","tissue: Bone marrow-derived mesenchymal stromal cells","agent: none","Five million detached BM-hMSCs were concentrated at 30 x 106 cells/ml in HBSS, without Ca2+ or Mg2+ (Gibco), containing 10 mM HEPES, 0.1 % human serum albumin (Sigma-Aldrich). Each sample was divided into two reaction tubes, buffer alone, and the other with 60 mU/ml of FTVI or FTVII (obtained from R&D Systems), as specified in each case, containing  1 mM GDP-fucose (Sigma-Aldrich) as enzyme substrate. Reactions were performed at 37 oC for 1 h with gentle shaking, followed by centrifugation and washing with DPBS.","BM mononuclear cells (BMMNC) were isolated by density gradient centrifugation over Histopaque-1077 (Sigma-Aldrich, St Louis, MO).  Human Platelet Lysate was obtained from platelet concentrates, which were frozen at –80 ºC for at least 3 days, thawed at 37 oC, transferred to sterile tubes and centrifuged at 900 g for 30 min; the supernatants were pooled, aliquoted and stored at –20ºC. BMMNC were seeded in culture flasks at 160,000 cells/cm2 using low glucose DMEM (GIBCO Invitrogen Corporation, Gran Island, NY, USA) supplemented with 5 % HPL, plus 50 U/ml penicillin and 50 U/ml streptomycin, and heparin (2U/ml) incubated at 37oC in a humid atmosphere with 5 % CO2. First change of medium was performed at 24 h and from this point twice per week. First passage was made when cells achieved 60-80% confluence. Culture media was removed and culture flasks were washed with DPBS, then incubated with TrypLE Select reagent (GIBCO Invitrogen Corporation, Gran Island, NY, USA). Cells were pooled, centrifuged at 700 g for 5 min and seeded at a density of 1,000 cells/cm2. After the third passage, BM-hMSCs were harvested.","total RNA","RNAs were isolated using the miRNeasy mini kit (Qiagen) protocol following the manufacturer's instructions","Cy3","Agilent Two Color Quick Amp Labeling and RNA Spike-In kits protocols following the manufacturer's instructions","9606","Test sample: mock-treated bone marrow-derived mesenchymal stromal cells sample OSP_V001-P3","Homo sapiens","tissue: Bone marrow-derived mesenchymal stromal cells sample OSP_V001-P3","agent: mock","Five million detached BM-hMSCs were concentrated at 30 x 106 cells/ml in HBSS, without Ca2+ or Mg2+ (Gibco), containing 10 mM HEPES, 0.1 % human serum albumin (Sigma-Aldrich). Each sample was divided into two reaction tubes, buffer alone, and the other with 60 mU/ml of FTVI or FTVII (obtained from R&D Systems), as specified in each case, containing  1 mM GDP-fucose (Sigma-Aldrich) as enzyme substrate. Reactions were performed at 37 oC for 1 h with gentle shaking, followed by centrifugation and washing with DPBS.","BM mononuclear cells (BMMNC) were isolated by density gradient centrifugation over Histopaque-1077 (Sigma-Aldrich, St Louis, MO).  Human Platelet Lysate was obtained from platelet concentrates, which were frozen at –80 ºC for at least 3 days, thawed at 37 oC, transferred to sterile tubes and centrifuged at 900 g for 30 min; the supernatants were pooled, aliquoted and stored at –20ºC. BMMNC were seeded in culture flasks at 160,000 cells/cm2 using low glucose DMEM (GIBCO Invitrogen Corporation, Gran Island, NY, USA) supplemented with 5 % HPL, plus 50 U/ml penicillin and 50 U/ml streptomycin, and heparin (2U/ml) incubated at 37oC in a humid atmosphere with 5 % CO2. First change of medium was performed at 24 h and from this point twice per week. First passage was made when cells achieved 60-80% confluence. Culture media was removed and culture flasks were washed with DPBS, then incubated with TrypLE Select reagent (GIBCO Invitrogen Corporation, Gran Island, NY, USA). Cells were pooled, centrifuged at 700 g for 5 min and seeded at a density of 1,000 cells/cm2. After the third passage, BM-hMSCs were harvested.","total RNA","RNAs were isolated using the miRNeasy mini kit (Qiagen) protocol following the manufacturer's instructions","Cy5","Agilent Two Color Quick Amp Labeling and RNA Spike-In kits protocols following the manufacturer's instructions","9606","Agilent Gene Expression Hybridization kit protocol following the manufacturer's instructions","Agilent G2565CA scanner, Agilent Scan Control software, scanning at 3µm","Agilent Feature Extraction software version 11.0.1.1","GPL16699","Antonio,,Parrado","antonio.parrado@carm.es","Hospital Clinico Universitario Virgen de la Arrixaca","Ctra. Madrid-Cartagena, s/n","Murcia","30120","Spain","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2399nnn/GSM2399040/suppl/GSM2399040_13C_OSP_V001_P3.txt.gz","62976","none","mock","Bone marrow-derived mesenchymal stromal cells","Bone marrow-derived mesenchymal stromal cells sample OSP_V001-P3"
"FTVII-treated BMSC sample OSP-V001-P3","GSM2399041","Public on Sep 05 2018","Nov 22 2016","Sep 05 2018","RNA","2","Reference sample: pool of 5 samples of bone marrow-derived mesenchymal stromal cells","Homo sapiens","tissue: Bone marrow-derived mesenchymal stromal cells","agent: none","Five million detached BM-hMSCs were concentrated at 30 x 106 cells/ml in HBSS, without Ca2+ or Mg2+ (Gibco), containing 10 mM HEPES, 0.1 % human serum albumin (Sigma-Aldrich). Each sample was divided into two reaction tubes, buffer alone, and the other with 60 mU/ml of FTVI or FTVII (obtained from R&D Systems), as specified in each case, containing  1 mM GDP-fucose (Sigma-Aldrich) as enzyme substrate. Reactions were performed at 37 oC for 1 h with gentle shaking, followed by centrifugation and washing with DPBS.","BM mononuclear cells (BMMNC) were isolated by density gradient centrifugation over Histopaque-1077 (Sigma-Aldrich, St Louis, MO).  Human Platelet Lysate was obtained from platelet concentrates, which were frozen at –80 ºC for at least 3 days, thawed at 37 oC, transferred to sterile tubes and centrifuged at 900 g for 30 min; the supernatants were pooled, aliquoted and stored at –20ºC. BMMNC were seeded in culture flasks at 160,000 cells/cm2 using low glucose DMEM (GIBCO Invitrogen Corporation, Gran Island, NY, USA) supplemented with 5 % HPL, plus 50 U/ml penicillin and 50 U/ml streptomycin, and heparin (2U/ml) incubated at 37oC in a humid atmosphere with 5 % CO2. First change of medium was performed at 24 h and from this point twice per week. First passage was made when cells achieved 60-80% confluence. Culture media was removed and culture flasks were washed with DPBS, then incubated with TrypLE Select reagent (GIBCO Invitrogen Corporation, Gran Island, NY, USA). Cells were pooled, centrifuged at 700 g for 5 min and seeded at a density of 1,000 cells/cm2. After the third passage, BM-hMSCs were harvested.","total RNA","RNAs were isolated using the miRNeasy mini kit (Qiagen) protocol following the manufacturer's instructions","Cy3","Agilent Two Color Quick Amp Labeling and RNA Spike-In kits protocols following the manufacturer's instructions","9606","Test sample: FTVII-treated bone marrow-derived mesenchymal stromal cells sample OSP_V001-P3","Homo sapiens","tissue: Bone marrow-derived mesenchymal stromal cells sample OSP_V001-P3","agent: FTVII","Five million detached BM-hMSCs were concentrated at 30 x 106 cells/ml in HBSS, without Ca2+ or Mg2+ (Gibco), containing 10 mM HEPES, 0.1 % human serum albumin (Sigma-Aldrich). Each sample was divided into two reaction tubes, buffer alone, and the other with 60 mU/ml of FTVI or FTVII (obtained from R&D Systems), as specified in each case, containing  1 mM GDP-fucose (Sigma-Aldrich) as enzyme substrate. Reactions were performed at 37 oC for 1 h with gentle shaking, followed by centrifugation and washing with DPBS.","BM mononuclear cells (BMMNC) were isolated by density gradient centrifugation over Histopaque-1077 (Sigma-Aldrich, St Louis, MO).  Human Platelet Lysate was obtained from platelet concentrates, which were frozen at –80 ºC for at least 3 days, thawed at 37 oC, transferred to sterile tubes and centrifuged at 900 g for 30 min; the supernatants were pooled, aliquoted and stored at –20ºC. BMMNC were seeded in culture flasks at 160,000 cells/cm2 using low glucose DMEM (GIBCO Invitrogen Corporation, Gran Island, NY, USA) supplemented with 5 % HPL, plus 50 U/ml penicillin and 50 U/ml streptomycin, and heparin (2U/ml) incubated at 37oC in a humid atmosphere with 5 % CO2. First change of medium was performed at 24 h and from this point twice per week. First passage was made when cells achieved 60-80% confluence. Culture media was removed and culture flasks were washed with DPBS, then incubated with TrypLE Select reagent (GIBCO Invitrogen Corporation, Gran Island, NY, USA). Cells were pooled, centrifuged at 700 g for 5 min and seeded at a density of 1,000 cells/cm2. After the third passage, BM-hMSCs were harvested.","total RNA","RNAs were isolated using the miRNeasy mini kit (Qiagen) protocol following the manufacturer's instructions","Cy5","Agilent Two Color Quick Amp Labeling and RNA Spike-In kits protocols following the manufacturer's instructions","9606","Agilent Gene Expression Hybridization kit protocol following the manufacturer's instructions","Agilent G2565CA scanner, Agilent Scan Control software, scanning at 3µm","Agilent Feature Extraction software version 11.0.1.1","GPL16699","Antonio,,Parrado","antonio.parrado@carm.es","Hospital Clinico Universitario Virgen de la Arrixaca","Ctra. Madrid-Cartagena, s/n","Murcia","30120","Spain","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2399nnn/GSM2399041/suppl/GSM2399041_13F_OSP_V001_P3.txt.gz","62976","none","FTVII","Bone marrow-derived mesenchymal stromal cells","Bone marrow-derived mesenchymal stromal cells sample OSP_V001-P3"
